ARCTURUS THERAPEUTICS HOLDINGS INC. Accrued Liabilities, Current
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Accrued Liabilities, Current of $22.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $22.85M.
- 2026-03-31: Accrued Liabilities, Current $22.67M.
- 2025-12-31: Accrued Liabilities, Current $23.90M.
- 2025-09-30: Accrued Liabilities, Current $19.38M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $22.85M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $22.67M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $23.90M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $19.38M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $24.63M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $30.56M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $38.78M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $32.40M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $35.45M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $34.77M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $31.88M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $28.55M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $28.76M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $32.29M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $30.23M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $25.53M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $33.61M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $19.97M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $23.52M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $52.36M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $42.61M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $29.80M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $19.39M 10-K · filed 2022-03-01 | $20.64M 10-K · filed 2021-03-01 |
| 2020-09-30 | $15.84M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $11.88M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.78M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $7.13M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $6.68M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.50M 10-Q · filed 2019-08-14 | |
| 2018-12-31 | $3.91M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |